ReP USP - Resultado da busca

Artigo de periodico
Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? (2023)
Zanetti, Maria Olívia Barboza ; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, ADESÃO À MEDICAÇÃO, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance?. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 348-357, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073469. Acesso em: 16 nov. 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? Journal of Oncology Pharmacy Practice, 29( 2), 348-357. doi:10.1177/10781552211073469
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/10781552211073469
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance? [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 348-357.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/10781552211073469
Artigo de periodico
Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences (2023)
Rodríguez‐Cano, Borja J.; Kohek, Maja ; Ona, Genís ; Alcázar‐Córcoles, Miguel Ángel; Santos, Rafael Guimarães dos ; Hallak, Jaime Eduardo Cecilio ; Bouso, José Carlos
Source: Drug and Alcohol Review. Unidade: FMRP
Subjects: ALUCINOGÊNICOS, TRANSTORNOS RELACIONADOS AO USO DE SUBSTÂNCIAS, ALCALOIDES, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRÍGUEZ‐CANO, Borja J. et al. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, v. 42, n. 2, p. 401-414, 2023Tradução . . Disponível em: https://doi.org/10.1111/dar.13587. Acesso em: 16 nov. 2024.
APA
Rodríguez‐Cano, B. J., Kohek, M., Ona, G., Alcázar‐Córcoles, M. Á., Santos, R. G. dos, Hallak, J. E. C., & Bouso, J. C. (2023). Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences. Drug and Alcohol Review, 42( 2), 401-414. doi:10.1111/dar.13587
NLM
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/dar.13587
Vancouver
Rodríguez‐Cano BJ, Kohek M, Ona G, Alcázar‐Córcoles MÁ, Santos RG dos, Hallak JEC, Bouso JC. Underground ibogaine use for the treatment of substance use disorders: aqualitative analysis of subjective experiences [Internet]. Drug and Alcohol Review. 2023 ; 42( 2): 401-414.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/dar.13587
Artigo de periodico
Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group (2023)
Wagner, Elias; Siskind, Dan; Falkai, Peter; Howes, Oliver; Correll, Christoph; Lee, Jimmy; Honer, William G.; Kane, John M.; Fernandez-Egea, Emilio; Barnes, Thomas R. E.; Hallak, Jaime Eduardo Cecilio
Source: Schizophrenia Bulletin. Unidade: FMRP
Subjects: TÉCNICA DELPHI, ESQUIZOFRENIA, TRANSTORNOS PSICÓTICOS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAGNER, Elias et al. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group. Schizophrenia Bulletin, v. 49, n. 4, p. 962-972, 2023Tradução . . Disponível em: https://doi.org/10.1093/schbul/sbad030. Acesso em: 16 nov. 2024.
APA
Wagner, E., Siskind, D., Falkai, P., Howes, O., Correll, C., Lee, J., et al. (2023). Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group. Schizophrenia Bulletin, 49( 4), 962-972. doi:10.1093/schbul/sbad030
NLM
Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, Honer WG, Kane JM, Fernandez-Egea E, Barnes TRE, Hallak JEC. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group [Internet]. Schizophrenia Bulletin. 2023 ; 49( 4): 962-972.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/schbul/sbad030
Vancouver
Wagner E, Siskind D, Falkai P, Howes O, Correll C, Lee J, Honer WG, Kane JM, Fernandez-Egea E, Barnes TRE, Hallak JEC. Clozapine optimization: a delphi consensus guideline from the treatment response and resistance in psychosis working group [Internet]. Schizophrenia Bulletin. 2023 ; 49( 4): 962-972.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/schbul/sbad030
Artigo de periodico
Vision-related quality of life in patients treated for ocular syphilis (2023)
Silva, Milena Simões Freitas e; Arantes, Tiago E.; Moreto, Renata; Smith, Justine R.; Furtado, João Marcello Fortes
Source: Scientific Reports. Unidade: FMRP
Subjects: ENDOFTALMITE, INFECÇÕES OCULARES BACTERIANAS, SÍFILIS, FARMACOTERAPIA, SÍFILIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Milena Simões Freitas e et al. Vision-related quality of life in patients treated for ocular syphilis. Scientific Reports, v. 13, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-023-40289-0. Acesso em: 16 nov. 2024.
APA
Silva, M. S. F. e, Arantes, T. E., Moreto, R., Smith, J. R., & Furtado, J. M. F. (2023). Vision-related quality of life in patients treated for ocular syphilis. Scientific Reports, 13. doi:10.1038/s41598-023-40289-0
NLM
Silva MSF e, Arantes TE, Moreto R, Smith JR, Furtado JMF. Vision-related quality of life in patients treated for ocular syphilis [Internet]. Scientific Reports. 2023 ; 13[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-023-40289-0
Vancouver
Silva MSF e, Arantes TE, Moreto R, Smith JR, Furtado JMF. Vision-related quality of life in patients treated for ocular syphilis [Internet]. Scientific Reports. 2023 ; 13[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-023-40289-0
Artigo de periodico
Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team (2023)
Zanetti, Maria Olívia Barboza ; Rodrigues, João Paulo Vilela; Varallo, Fabiana Rossi ; Cunha, Renato Luiz Guerino ; Simões, Belinda Pinto ; Pereira, Leonardo Régis Leira
Source: Journal of Oncology Pharmacy Practice. Unidades: EERP, FCFRP, FMRP
Subjects: DOENÇA ENXERTO-HOSPEDEIRO, TRANSPLANTE DE ÓRGÃOS, CÉLULAS-TRONCO, HOSPITALIZAÇÃO, SERVIÇOS FARMACÊUTICOS, FARMACOTERAPIA, ESTUDOS RETROSPECTIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Maria Olívia Barboza et al. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, v. 29, n. 2, p. 375-385, 2023Tradução . . Disponível em: https://doi.org/10.1177/10781552211073797. Acesso em: 16 nov. 2024.
APA
Zanetti, M. O. B., Rodrigues, J. P. V., Varallo, F. R., Cunha, R. L. G., Simões, B. P., & Pereira, L. R. L. (2023). Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team. Journal of Oncology Pharmacy Practice, 29( 2), 375-385. doi:10.1177/10781552211073797
NLM
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/10781552211073797
Vancouver
Zanetti MOB, Rodrigues JPV, Varallo FR, Cunha RLG, Simões BP, Pereira LRL. Impact of the insertion of the clinical pharmacist in the Allogeneic Hematopoietic Stem Cells Transplantation team [Internet]. Journal of Oncology Pharmacy Practice. 2023 ; 29( 2): 375-385.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/10781552211073797
Artigo de periodico
Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study (2022)
Guimarães, Mayra Cristina da Luz Pádua; Coelho, Juliana Chaves; Santos, Juliano dos; Higa, Camila Braga de Oliveira; Flórido, Carime Farah; Lee, Renata Jae Won; Paes, Grazielli Soares; Silva, Giovanio Vieira da; Drager, Luciano Ferreira; Pierin, Angela Maria Geraldo
Source: Clinical Hypertension. Unidades: FM, EE
Subjects: HIPERTENSÃO, COVID-19, FARMACOTERAPIA, ADESÃO À MEDICAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIMARÃES, Mayra Cristina da Luz Pádua et al. Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study. Clinical Hypertension, v. 28, n. 35, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1186/s40885-022-00219-0. Acesso em: 16 nov. 2024.
APA
Guimarães, M. C. da L. P., Coelho, J. C., Santos, J. dos, Higa, C. B. de O., Flórido, C. F., Lee, R. J. W., et al. (2022). Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study. Clinical Hypertension, 28( 35), 1-10. doi:10.1186/s40885-022-00219-0
NLM
Guimarães MC da LP, Coelho JC, Santos J dos, Higa CB de O, Flórido CF, Lee RJW, Paes GS, Silva GV da, Drager LF, Pierin AMG. Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study [Internet]. Clinical Hypertension. 2022 ; 28( 35): 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s40885-022-00219-0
Vancouver
Guimarães MC da LP, Coelho JC, Santos J dos, Higa CB de O, Flórido CF, Lee RJW, Paes GS, Silva GV da, Drager LF, Pierin AMG. Adherence to antihypertensive treatment during the COVID-19 pandemic: findings from a cross-sectional study [Internet]. Clinical Hypertension. 2022 ; 28( 35): 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1186/s40885-022-00219-0
Artigo de periodico
Paclitaxel binds and activates C5aR1: a new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions (2022)
Brandolini, Laura; d’Angelo, Michele; Novelli, Rubina; Castelli, Vanessa; Giorgio, Cristina; Sirico, Anna; Cocchiaro, Pasquale; D’Egidio, Francesco; Benedetti, Elisabetta; Cristiano, Claudia; Bugatti, Antonella; Quadros, Andreza Urba de; Cunha, Thiago Mattar
Source: Cell Death & Disease. Unidade: FMRP
Subjects: ANTINEOPLÁSICOS, DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO, FARMACOTERAPIA, DOR CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANDOLINI, Laura et al. Paclitaxel binds and activates C5aR1: a new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions. Cell Death & Disease, v. 13, n. 5, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41419-022-04964-w. Acesso em: 16 nov. 2024.
APA
Brandolini, L., d’Angelo, M., Novelli, R., Castelli, V., Giorgio, C., Sirico, A., et al. (2022). Paclitaxel binds and activates C5aR1: a new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions. Cell Death & Disease, 13( 5), 1-15. doi:10.1038/s41419-022-04964-w
NLM
Brandolini L, d’Angelo M, Novelli R, Castelli V, Giorgio C, Sirico A, Cocchiaro P, D’Egidio F, Benedetti E, Cristiano C, Bugatti A, Quadros AU de, Cunha TM. Paclitaxel binds and activates C5aR1: a new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions [Internet]. Cell Death & Disease. 2022 ; 13( 5): 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41419-022-04964-w
Vancouver
Brandolini L, d’Angelo M, Novelli R, Castelli V, Giorgio C, Sirico A, Cocchiaro P, D’Egidio F, Benedetti E, Cristiano C, Bugatti A, Quadros AU de, Cunha TM. Paclitaxel binds and activates C5aR1: a new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions [Internet]. Cell Death & Disease. 2022 ; 13( 5): 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41419-022-04964-w
Artigo de periodico
Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma (2022)
Tavares, Marcela de Oliveira ; Milan, Thais Moré; Bighetti-Trevisan, Rayana Longo ; Leopoldino, Andréia Machado ; Almeida, Luciana Oliveira de
Source: Journal of Oral Pathology & Medicine. Unidades: FCFRP, FORP
Subjects: CARCINOMA DE CÉLULAS ESCAMOSAS, FARMACOTERAPIA, LINHAGEM CELULAR, NEOPLASIAS, NEOPLASIAS DE CABEÇA E PESCOÇO, NEOPLASIAS BUCAIS, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Marcela de Oliveira et al. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, v. 51, n. 6, p. 529-537, 2022Tradução . . Disponível em: https://doi.org/10.1111/jop.13326. Acesso em: 16 nov. 2024.
APA
Tavares, M. de O., Milan, T. M., Bighetti-Trevisan, R. L., Leopoldino, A. M., & Almeida, L. O. de. (2022). Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma. Journal of Oral Pathology & Medicine, 51( 6), 529-537. doi:10.1111/jop.13326
NLM
Tavares M de O, Milan TM, Bighetti-Trevisan RL, Leopoldino AM, Almeida LO de. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma [Internet]. Journal of Oral Pathology & Medicine. 2022 ; 51( 6): 529-537.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jop.13326
Vancouver
Tavares M de O, Milan TM, Bighetti-Trevisan RL, Leopoldino AM, Almeida LO de. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma [Internet]. Journal of Oral Pathology & Medicine. 2022 ; 51( 6): 529-537.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/jop.13326
Artigo de periodico-carta/editorial
Nurses: an underused, vital asset against drug-resistant infections (2022)
Castro-Sánchez, Enrique; Bosanquet, Jo; Courtenay, Molly; Gallagher, Rose; Gotterson, Fiona; Manias, Elizabeth; McEwen, Jo; Ness, Val; Olans, Rita; Padoveze, Maria Clara ; Toit, Briette du; Bennasar-Veny, Miquel
Source: the Lancet. Unidade: EE
Subjects: INFECÇÕES BACTERIANAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO-SÁNCHEZ, Enrique et al. Nurses: an underused, vital asset against drug-resistant infections. the Lancet. London: Escola de Enfermagem, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(22)01531-8. Acesso em: 16 nov. 2024. , 2022
APA
Castro-Sánchez, E., Bosanquet, J., Courtenay, M., Gallagher, R., Gotterson, F., Manias, E., et al. (2022). Nurses: an underused, vital asset against drug-resistant infections. the Lancet. London: Escola de Enfermagem, Universidade de São Paulo. doi:10.1016/S0140-6736(22)01531-8
NLM
Castro-Sánchez E, Bosanquet J, Courtenay M, Gallagher R, Gotterson F, Manias E, McEwen J, Ness V, Olans R, Padoveze MC, Toit B du, Bennasar-Veny M. Nurses: an underused, vital asset against drug-resistant infections [Internet]. the Lancet. 2022 ; 400( 10354): 729.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(22)01531-8
Vancouver
Castro-Sánchez E, Bosanquet J, Courtenay M, Gallagher R, Gotterson F, Manias E, McEwen J, Ness V, Olans R, Padoveze MC, Toit B du, Bennasar-Veny M. Nurses: an underused, vital asset against drug-resistant infections [Internet]. the Lancet. 2022 ; 400( 10354): 729.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(22)01531-8
Artigo de periodico
Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments (2022)
Bayer, Hugo; Stern, Cristina A. J.; Troyner, Fernanda; Gazarini, Lucas; Guimarães, Francisco Silveira ; Bertoglio, Leandro J.
Source: Neuropharmacology. Unidade: FMRP
Subjects: COMPORTAMENTO, CANABINOIDES, TRANSTORNOS DA MEMÓRIA, FARMACOTERAPIA, PLASTICIDADE NEURONAL, CÓRTEX PRÉ-FRONTAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAYER, Hugo et al. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, v. 205, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2021.108913. Acesso em: 16 nov. 2024.
APA
Bayer, H., Stern, C. A. J., Troyner, F., Gazarini, L., Guimarães, F. S., & Bertoglio, L. J. (2022). Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments. Neuropharmacology, 205, 1-11. doi:10.1016/j.neuropharm.2021.108913
NLM
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Vancouver
Bayer H, Stern CAJ, Troyner F, Gazarini L, Guimarães FS, Bertoglio LJ. Medial prefrontal cortex mechanisms of cannabidiol-induced aversive memory reconsolidation impairments [Internet]. Neuropharmacology. 2022 ; 205 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.neuropharm.2021.108913
Artigo de periodico
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze (2022)
Fabris, Débora; Carvalho, Milene Cristina de ; Brandão, Marcus Lira ; Prado, Wiliam Alves do; Zuardi, Antônio Waldo ; Crippa, José Alexandre de Souza ; Oliveira, Amanda R. de; Lovick, Thelma A.; Genaro, Karina
Source: Journal of Psychopharmacology. Unidades: FMRP, FFCLRP
Subjects: ANSIEDADE, ANTIDEPRESSIVOS, FARMACOTERAPIA, CANABINOIDES, DIFERENÇAS SEXUAIS ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRIS, Débora et al. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, v. 36, n. 12, p. 1371-1383, 2022Tradução . . Disponível em: https://doi.org/10.1177/02698811221125440. Acesso em: 16 nov. 2024.
APA
Fabris, D., Carvalho, M. C. de, Brandão, M. L., Prado, W. A. do, Zuardi, A. W., Crippa, J. A. de S., et al. (2022). Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze. Journal of Psychopharmacology, 36( 12), 1371-1383. doi:10.1177/02698811221125440
NLM
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/02698811221125440
Vancouver
Fabris D, Carvalho MC de, Brandão ML, Prado WA do, Zuardi AW, Crippa JA de S, Oliveira AR de, Lovick TA, Genaro K. Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze [Internet]. Journal of Psychopharmacology. 2022 ; 36( 12): 1371-1383.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/02698811221125440
Artigo de periodico
Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota (2022)
Arruda, José Alcides Almeida de ; Corrêa, Jôice Dias ; Singh, Youvika ; Oliveira, Sicília Rezende ; Machado, Caio Cavalcante ; Schneider, Ayda Henriques ; Medeiros, Julliane Dutra ; Fernandes, Gabriel R; Macari, Soraia ; Barrioni, Breno Rocha ; Santos, Mariana de Souza; Rodrigues, Letícia Fernanda Duffles ; Nakaya, Helder Takashi Imoto ; Fukada, Sandra Yasuyo ; Graves, Dana T ; Cunha, Fernando Queiroz ; Silva, Tarcília Aparecida
Source: Anaerobe. Unidades: FMRP, FCFRP, FCF, FORP
Subjects: ARTRITE REUMATOIDE, FARMACOTERAPIA, METOTREXATO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, José Alcides Almeida de et al. Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota. Anaerobe, v. 75, p. 1-11 art. 102577, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.anaerobe.2022.102577. Acesso em: 16 nov. 2024.
APA
Arruda, J. A. A. de, Corrêa, J. D., Singh, Y., Oliveira, S. R., Machado, C. C., Schneider, A. H., et al. (2022). Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota. Anaerobe, 75, 1-11 art. 102577. doi:10.1016/j.anaerobe.2022.102577
NLM
Arruda JAA de, Corrêa JD, Singh Y, Oliveira SR, Machado CC, Schneider AH, Medeiros JD, Fernandes GR, Macari S, Barrioni BR, Santos M de S, Rodrigues LFD, Nakaya HTI, Fukada SY, Graves DT, Cunha FQ, Silva TA. Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota [Internet]. Anaerobe. 2022 ; 75 1-11 art. 102577.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.anaerobe.2022.102577
Vancouver
Arruda JAA de, Corrêa JD, Singh Y, Oliveira SR, Machado CC, Schneider AH, Medeiros JD, Fernandes GR, Macari S, Barrioni BR, Santos M de S, Rodrigues LFD, Nakaya HTI, Fukada SY, Graves DT, Cunha FQ, Silva TA. Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota [Internet]. Anaerobe. 2022 ; 75 1-11 art. 102577.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.anaerobe.2022.102577
Parte de monografia/livro
Advances in polymeric nanoparticles for drug delivery systems in cancer: Production and characterization (2021)
Feitosa, Valker Araujo ; Pinto, Terezinha de Jesus Andreoli ; Dua, Kamal ; Cerize, Natalia Neto Pereira
Source: Advanced drug delivery systems in the management of cancer. Unidades: FCF, BIOTECNOLOGIA
Subjects: NANOPARTÍCULAS, QUIMIOTERÁPICOS, NEOPLASIAS, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FEITOSA, Valker Araujo et al. Advances in polymeric nanoparticles for drug delivery systems in cancer: Production and characterization. Advanced drug delivery systems in the management of cancer. Tradução . London: Academic Press, 2021. . . Acesso em: 16 nov. 2024.
APA
Feitosa, V. A., Pinto, T. de J. A., Dua, K., & Cerize, N. N. P. (2021). Advances in polymeric nanoparticles for drug delivery systems in cancer: Production and characterization. In Advanced drug delivery systems in the management of cancer. London: Academic Press.
NLM
Feitosa VA, Pinto T de JA, Dua K, Cerize NNP. Advances in polymeric nanoparticles for drug delivery systems in cancer: Production and characterization. In: Advanced drug delivery systems in the management of cancer. London: Academic Press; 2021. [citado 2024 nov. 16 ]
Vancouver
Feitosa VA, Pinto T de JA, Dua K, Cerize NNP. Advances in polymeric nanoparticles for drug delivery systems in cancer: Production and characterization. In: Advanced drug delivery systems in the management of cancer. London: Academic Press; 2021. [citado 2024 nov. 16 ]
Artigo de periodico
A living WHO guideline on drugs to prevent covid-19 (2021)
Lamontagne, Francois; Agoritsas, Thomas; Siemieniuk, Reed; Rochwerg, Bram; Bartoszko, Jessica; Askie, Lisa; Macdonald, Helen; Amin, Wagdy; Bausch, Frederique Jacquerioz; Dourado, Letícia Kawano; Souza, João Paulo Dias de; Stegemann, Miriam
Source: BMJ. Unidade: FMRP
Subjects: HORMÔNIOS DO CÓRTEX ADRENAL, COVID-19, INFECÇÕES POR CORONAVIRUS, PANDEMIAS, PNEUMONIA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAMONTAGNE, Francois et al. A living WHO guideline on drugs to prevent covid-19. BMJ, v. 372, 2021Tradução . . Disponível em: https://doi.org/10.1136/bmj.n526. Acesso em: 16 nov. 2024.
APA
Lamontagne, F., Agoritsas, T., Siemieniuk, R., Rochwerg, B., Bartoszko, J., Askie, L., et al. (2021). A living WHO guideline on drugs to prevent covid-19. BMJ, 372. doi:10.1136/bmj.n526
NLM
Lamontagne F, Agoritsas T, Siemieniuk R, Rochwerg B, Bartoszko J, Askie L, Macdonald H, Amin W, Bausch FJ, Dourado LK, Souza JPD de, Stegemann M. A living WHO guideline on drugs to prevent covid-19 [Internet]. BMJ. 2021 ; 372[citado 2024 nov. 16 ] Available from: https://doi.org/10.1136/bmj.n526
Vancouver
Lamontagne F, Agoritsas T, Siemieniuk R, Rochwerg B, Bartoszko J, Askie L, Macdonald H, Amin W, Bausch FJ, Dourado LK, Souza JPD de, Stegemann M. A living WHO guideline on drugs to prevent covid-19 [Internet]. BMJ. 2021 ; 372[citado 2024 nov. 16 ] Available from: https://doi.org/10.1136/bmj.n526
Artigo de periodico
Celecoxib treatment dampens LPS-induced periapical bone resorption in a mouse model (2021)
Petean, Igor Bassi Ferreira ; Almeida Junior, Luciano Aparecido de; Arnez, Maya Fernanda Manfrin; Queiroz, Alexandra Mussolino de ; Segato, Raquel Assed Bezerra da Silva; Silva, Léa Assed Bezerra da ; Faccioli, Lucia Helena ; Paula-Silva, Francisco Wanderley Garcia de
Source: International Endodontic Journal. Unidades: FORP, FCFRP, RUSP
Subjects: REABSORÇÃO ÓSSEA DE ANIMAL, FARMACOTERAPIA, ANALGÉSICOS, ANTI-INFLAMATÓRIOS, ESCHERICHIA COLI, LIPOPOLISSACARÍDEOS, OSTEOCLASTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETEAN, Igor Bassi Ferreira et al. Celecoxib treatment dampens LPS-induced periapical bone resorption in a mouse model. International Endodontic Journal, v. 54, n. 8, p. 1289-1299, 2021Tradução . . Disponível em: https://doi.org/10.1111/iej.13472. Acesso em: 16 nov. 2024.
APA
Petean, I. B. F., Almeida Junior, L. A. de, Arnez, M. F. M., Queiroz, A. M. de, Segato, R. A. B. da S., Silva, L. A. B. da, et al. (2021). Celecoxib treatment dampens LPS-induced periapical bone resorption in a mouse model. International Endodontic Journal, 54( 8), 1289-1299. doi:10.1111/iej.13472
NLM
Petean IBF, Almeida Junior LA de, Arnez MFM, Queiroz AM de, Segato RAB da S, Silva LAB da, Faccioli LH, Paula-Silva FWG de. Celecoxib treatment dampens LPS-induced periapical bone resorption in a mouse model [Internet]. International Endodontic Journal. 2021 ; 54( 8): 1289-1299.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/iej.13472
Vancouver
Petean IBF, Almeida Junior LA de, Arnez MFM, Queiroz AM de, Segato RAB da S, Silva LAB da, Faccioli LH, Paula-Silva FWG de. Celecoxib treatment dampens LPS-induced periapical bone resorption in a mouse model [Internet]. International Endodontic Journal. 2021 ; 54( 8): 1289-1299.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/iej.13472
Artigo de periodico
Intradermal methylene blue administration on the progression of burn injuries (2021)
Beldi, Vinícius F. M.; Rosique, Marina Junqueira Ferreira; Tirapelli, Luis Fernando; Moriguti, Eny Kiyomi Uemura; Nunes, Altacilio Aparecido ; Farina Júnior, Jayme Adriano; Evora, Paulo Roberto Barbosa
Source: Journal of Wound Care. Unidade: FMRP
Subjects: QUEIMADURAS, FARMACOTERAPIA, AZUL DE METILENO, NECROSE, ÓXIDO NÍTRICO, CICATRIZAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BELDI, Vinícius F. M. et al. Intradermal methylene blue administration on the progression of burn injuries. Journal of Wound Care, v. 30, p. VIIIi-VIIIx, 2021Tradução . . Disponível em: https://doi.org/10.12968/jowc.2021.30.Sup9a.VIII. Acesso em: 16 nov. 2024.
APA
Beldi, V. F. M., Rosique, M. J. F., Tirapelli, L. F., Moriguti, E. K. U., Nunes, A. A., Farina Júnior, J. A., & Evora, P. R. B. (2021). Intradermal methylene blue administration on the progression of burn injuries. Journal of Wound Care, 30, VIIIi-VIIIx. doi:10.12968/jowc.2021.30.Sup9a.VIII
NLM
Beldi VFM, Rosique MJF, Tirapelli LF, Moriguti EKU, Nunes AA, Farina Júnior JA, Evora PRB. Intradermal methylene blue administration on the progression of burn injuries [Internet]. Journal of Wound Care. 2021 ; 30 VIIIi-VIIIx.[citado 2024 nov. 16 ] Available from: https://doi.org/10.12968/jowc.2021.30.Sup9a.VIII
Vancouver
Beldi VFM, Rosique MJF, Tirapelli LF, Moriguti EKU, Nunes AA, Farina Júnior JA, Evora PRB. Intradermal methylene blue administration on the progression of burn injuries [Internet]. Journal of Wound Care. 2021 ; 30 VIIIi-VIIIx.[citado 2024 nov. 16 ] Available from: https://doi.org/10.12968/jowc.2021.30.Sup9a.VIII
Artigo de periodico
Cannabidiol induces autophagy via ERK1/2 activation in neural cells (2021)
Vrechi, Talita Aparecida de Moraes; Leão, Anderson H. F. F.; Morais, Ingrid B. M.; Abilio, Vanessa Costhek; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Bincoletto, Cláudia; Ureshino, Rodrigo P.; Smaili, Soraya Soubhi; Pereira, Gustavo José da Silva
Source: Scientific Reports. Unidade: FMRP
Subjects: CANABINOIDES, LINHAGEM CELULAR, DOENÇAS NEURODEGENERATIVAS, NEUROBLASTOMA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VRECHI, Talita Aparecida de Moraes et al. Cannabidiol induces autophagy via ERK1/2 activation in neural cells. Scientific Reports, v. 11, n. 1, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41598-021-84879-2. Acesso em: 16 nov. 2024.
APA
Vrechi, T. A. de M., Leão, A. H. F. F., Morais, I. B. M., Abilio, V. C., Zuardi, A. W., Hallak, J. E. C., et al. (2021). Cannabidiol induces autophagy via ERK1/2 activation in neural cells. Scientific Reports, 11( 1). doi:10.1038/s41598-021-84879-2
NLM
Vrechi TA de M, Leão AHFF, Morais IBM, Abilio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Ureshino RP, Smaili SS, Pereira GJ da S. Cannabidiol induces autophagy via ERK1/2 activation in neural cells [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-021-84879-2
Vancouver
Vrechi TA de M, Leão AHFF, Morais IBM, Abilio VC, Zuardi AW, Hallak JEC, Crippa JA de S, Bincoletto C, Ureshino RP, Smaili SS, Pereira GJ da S. Cannabidiol induces autophagy via ERK1/2 activation in neural cells [Internet]. Scientific Reports. 2021 ; 11( 1):[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-021-84879-2
Artigo de periodico
Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure (2021)
Cavalcante, Gisele Lopes; Brognara, Fernanda ; Oliveira, Lucas Vaz de C.; Lataro, Renata M.; Durand, Marina de T.; Oliveira, Aldeidia P. de; Nóbrega, Antônio Cláudio L. da; Salgado, Hélio César ; Sabino, João Paulo J.
Source: Acta Physiologica. Unidades: FMRP, EERP
Subjects: ESTIMULAÇÃO ELÉTRICA, SISTEMA NERVOSO AUTÔNOMO, BARORREFLEXO, INSUFICIÊNCIA CARDÍACA, HIPERTENSÃO, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALCANTE, Gisele Lopes et al. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure. Acta Physiologica, v. 232, n. 3, p. 1-28, 2021Tradução . . Disponível em: https://doi.org/10.1111/apha.13663. Acesso em: 16 nov. 2024.
APA
Cavalcante, G. L., Brognara, F., Oliveira, L. V. de C., Lataro, R. M., Durand, M. de T., Oliveira, A. P. de, et al. (2021). Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure. Acta Physiologica, 232( 3), 1-28. doi:10.1111/apha.13663
NLM
Cavalcante GL, Brognara F, Oliveira LV de C, Lataro RM, Durand M de T, Oliveira AP de, Nóbrega ACL da, Salgado HC, Sabino JPJ. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure [Internet]. Acta Physiologica. 2021 ; 232( 3): 1-28.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/apha.13663
Vancouver
Cavalcante GL, Brognara F, Oliveira LV de C, Lataro RM, Durand M de T, Oliveira AP de, Nóbrega ACL da, Salgado HC, Sabino JPJ. Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure [Internet]. Acta Physiologica. 2021 ; 232( 3): 1-28.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/apha.13663
Artigo de periodico
A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir (2021)
Campos, Guilherme Rodrigues Fernandes; Ward, Joseph; Chen, Shucheng; Bittar, Cíntia; Rodrigues, João Paulo Vilela; Martinelli, Ana de Lourdes Candolo; Souza, Fernanda Fernandes; Pereira, Leonardo Régis Leira ; Rahal, Paula; Harris, Mark
Source: Journal of General Virology. Unidades: FCFRP, FMRP
Subjects: ANTIVIRAIS, LINHAGEM CELULAR, ESTUDOS DE COORTES, FARMACOTERAPIA, HEPATITE C, MUTAÇÃO, REPLICAÇÃO VIRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Guilherme Rodrigues Fernandes et al. A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir. Journal of General Virology, v. 102, n. 1, p. 11-7, 2021Tradução . . Disponível em: https://doi.org/10.1099/jgv.0.001496. Acesso em: 16 nov. 2024.
APA
Campos, G. R. F., Ward, J., Chen, S., Bittar, C., Rodrigues, J. P. V., Martinelli, A. de L. C., et al. (2021). A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir. Journal of General Virology, 102( 1), 11-7. doi:10.1099/jgv.0.001496
NLM
Campos GRF, Ward J, Chen S, Bittar C, Rodrigues JPV, Martinelli A de LC, Souza FF, Pereira LRL, Rahal P, Harris M. A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir [Internet]. Journal of General Virology. 2021 ; 102( 1): 11-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1099/jgv.0.001496
Vancouver
Campos GRF, Ward J, Chen S, Bittar C, Rodrigues JPV, Martinelli A de LC, Souza FF, Pereira LRL, Rahal P, Harris M. A novel substitution in NS5A enhances the resistance of hepatitis C virus genotype 3 to daclatasvir [Internet]. Journal of General Virology. 2021 ; 102( 1): 11-7.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1099/jgv.0.001496
Artigo de periodico
Clinical treatment for hepatitis C reverses CYP2C19 inhibition (2021)
Pippa, Leandro Francisco ; Vieira, Carolina Pinto; Caris, Juciene Aparecida; Rocha, Adriana; Garcia, Camile Prates; Rezende, Rosamar Eulira Fontes; Lanchote, Vera Lucia
Source: British Journal of Clinical Pharmacology. Unidade: FCFRP
Subjects: ANTIVIRAIS, CITOCROMO P-450, FLAVIVIRIDAE, HEPATITE C, HEPATITE CRÔNICA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Clinical treatment for hepatitis C reverses CYP2C19 inhibition. British Journal of Clinical Pharmacology, v. 87, n. 10, p. 4013-4019, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14829. Acesso em: 16 nov. 2024.
APA
Pippa, L. F., Vieira, C. P., Caris, J. A., Rocha, A., Garcia, C. P., Rezende, R. E. F., & Lanchote, V. L. (2021). Clinical treatment for hepatitis C reverses CYP2C19 inhibition. British Journal of Clinical Pharmacology, 87( 10), 4013-4019. doi:10.1111/bcp.14829
NLM
Pippa LF, Vieira CP, Caris JA, Rocha A, Garcia CP, Rezende REF, Lanchote VL. Clinical treatment for hepatitis C reverses CYP2C19 inhibition [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 10): 4013-4019.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcp.14829
Vancouver
Pippa LF, Vieira CP, Caris JA, Rocha A, Garcia CP, Rezende REF, Lanchote VL. Clinical treatment for hepatitis C reverses CYP2C19 inhibition [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 10): 4013-4019.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1111/bcp.14829

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration